TOXICITY STUDIES ON TE-031 (A-56268) IX CHRONIC TOXICITY IN RATS
TE-031 (A-56268), a new macrolide antibiotic, was administered orally to Wistar rats at doses of 1.6, 8, 40 and 200 mg/kg/day for 6 months to determine the chronic toxicity of the drug and recovery in the 2- month withdrawal period. The results are as follows. 1. No deaths occurred during the treatm...
Saved in:
Published in | CHEMOTHERAPY Vol. 36; no. Supplement3; pp. 311 - 333 |
---|---|
Main Authors | , , , , , |
Format | Journal Article |
Language | Japanese |
Published |
Japanese Society of Chemotherapy
1988
|
Online Access | Get full text |
Cover
Loading…
Abstract | TE-031 (A-56268), a new macrolide antibiotic, was administered orally to Wistar rats at doses of 1.6, 8, 40 and 200 mg/kg/day for 6 months to determine the chronic toxicity of the drug and recovery in the 2- month withdrawal period. The results are as follows. 1. No deaths occurred during the treatment and increased caecum weight was seen in all except the 40 mg/kg group. No other changes were observed in the 8 mg/kg or less groups. 2. In the 40 mg/kg group, salivation was sporadically seen and elevation of GPT levels was noted. Pathological examination revealed increased multinucleated hepatocytes, necrosis of hepatocytes and increased small round cell infiltration. 3. In addition to the above changes, animals in the 200 mg/kg group showed a slight decrease in body weight gain, increased sodium and decreased potassium values in urine, slight anemic changes, elevation of GPT and Al- P levels, decreased lipid and albumin levels. Pathological examination showed increase in liver, spleen and adrenal gland weight, and hepatotoxicity (in the 200 mg/kg group) was marked in comparison with the 40 mg/kg group. 4. The effects of TE- 031 were observed at dose levels of 40 mg/kg or more. These changes generally regressed or normalized in the recovery test. The no-effect dose of TE-031 was considered to be 8 mg/kg in the present study. |
---|---|
AbstractList | TE-031 (A-56268), a new macrolide antibiotic, was administered orally to Wistar rats at doses of 1.6, 8, 40 and 200 mg/kg/day for 6 months to determine the chronic toxicity of the drug and recovery in the 2- month withdrawal period. The results are as follows. 1. No deaths occurred during the treatment and increased caecum weight was seen in all except the 40 mg/kg group. No other changes were observed in the 8 mg/kg or less groups. 2. In the 40 mg/kg group, salivation was sporadically seen and elevation of GPT levels was noted. Pathological examination revealed increased multinucleated hepatocytes, necrosis of hepatocytes and increased small round cell infiltration. 3. In addition to the above changes, animals in the 200 mg/kg group showed a slight decrease in body weight gain, increased sodium and decreased potassium values in urine, slight anemic changes, elevation of GPT and Al- P levels, decreased lipid and albumin levels. Pathological examination showed increase in liver, spleen and adrenal gland weight, and hepatotoxicity (in the 200 mg/kg group) was marked in comparison with the 40 mg/kg group. 4. The effects of TE- 031 were observed at dose levels of 40 mg/kg or more. These changes generally regressed or normalized in the recovery test. The no-effect dose of TE-031 was considered to be 8 mg/kg in the present study. |
Author | KIMURA, MASAAKI IWAMATSU, YUKO KASAI, AKIRA OHSHIMA, TAKASHI NAKANE, SADAO YAGI, KENICHI |
Author_xml | – sequence: 1 fullname: OHSHIMA, TAKASHI organization: Research Center, Taisho Pharmaceutical Co., Ltd – sequence: 2 fullname: YAGI, KENICHI organization: Research Center, Taisho Pharmaceutical Co., Ltd – sequence: 3 fullname: KASAI, AKIRA organization: Research Center, Taisho Pharmaceutical Co., Ltd – sequence: 4 fullname: IWAMATSU, YUKO organization: Research Center, Taisho Pharmaceutical Co., Ltd – sequence: 5 fullname: KIMURA, MASAAKI organization: Research Center, Taisho Pharmaceutical Co., Ltd – sequence: 6 fullname: NAKANE, SADAO organization: Research Center, Taisho Pharmaceutical Co., Ltd |
BookMark | eNpdj0FPwjAYhhuDiYj8h93UxGK_fm3XHglOXULkwEjwVLvtm0BgLNs88O896EE5PXkPz5s812xQH2ti7AHEBEBq8Vhs6HDsN9SG5gRO4wTNZPnVNHs6UN2jR4ALNgRrFdfWqQEbCiEcRzD6io27bpsLASCMtHLIbrPFOp2l2Xu0zFZPabKMFm9RlnCBEN1NuTbS2PsoXd-wyyrsOxr_csRWz0k2e-XzxUs6m875ToLqeaWgUA5iZ0qNRJXOS1lZW2IuY5FjRajjvNSylM6GQpDUoEOslVQhrpwiHLGPn99d14dP8k27PYT25EPbb4s9-fN4j8b_iz-bAH_U0Hqq8Rs922Bw |
ContentType | Journal Article |
Copyright | Japanese Society of Chemotherapy |
Copyright_xml | – notice: Japanese Society of Chemotherapy |
DOI | 10.11250/chemotherapy1953.36.Supplement3_311 |
DatabaseTitleList | |
DeliveryMethod | fulltext_linktorsrc |
EISSN | 1884-5894 |
EndPage | 333 |
ExternalDocumentID | article_chemotherapy1953_36_Supplement3_36_Supplement3_311_article_char_en |
GroupedDBID | 53G AAUGY ADBBV ALMA_UNASSIGNED_HOLDINGS BAWUL DIK JSF JSH KQ8 RJT RZJ ZOHVM |
ID | FETCH-LOGICAL-j214t-f41c491796d53eef5bd2f88d3b270b3fe357bd52d298ac0e2515a75424a7f94e3 |
ISSN | 0009-3165 |
IngestDate | Thu Aug 17 20:29:13 EDT 2023 |
IsDoiOpenAccess | true |
IsOpenAccess | true |
IsPeerReviewed | false |
IsScholarly | false |
Issue | Supplement3 |
Language | Japanese |
LinkModel | OpenURL |
MergedId | FETCHMERGED-LOGICAL-j214t-f41c491796d53eef5bd2f88d3b270b3fe357bd52d298ac0e2515a75424a7f94e3 |
OpenAccessLink | https://www.jstage.jst.go.jp/article/chemotherapy1953/36/Supplement3/36_Supplement3_311/_article/-char/en |
PageCount | 23 |
ParticipantIDs | jstage_primary_article_chemotherapy1953_36_Supplement3_36_Supplement3_311_article_char_en |
PublicationCentury | 1900 |
PublicationDate | 1988-00-00 |
PublicationDateYYYYMMDD | 1988-01-01 |
PublicationDate_xml | – year: 1988 text: 1988-00-00 |
PublicationDecade | 1980 |
PublicationTitle | CHEMOTHERAPY |
PublicationTitleAlternate | Chemother. |
PublicationYear | 1988 |
Publisher | Japanese Society of Chemotherapy |
Publisher_xml | – name: Japanese Society of Chemotherapy |
References | 3) 阪川隆司, 筒井良文, 川西正彦, 木村正明, 樽本保男, 中根貞雄, 須藤鎮世: TE-031の毒性研究 (第6報) イヌの急性および亜急性毒性試験. 基礎と臨床22 (7): 1453-1483, 1988 7) 今村和憲, 鈴木弘, 吉田俊雄, 岡宮英明, 尾崎浩, 塩原有一: Cefotetan (YM 09330) のラットにおける腹腔内投与5週間毒性試験. Chemotherapy30 (S-1): 213-227, 1982 9) 高橋日出彦: 一般毒性検出法. くすりの毒性: 82頁, 南江堂, 1973 6) 今井章浩, 森下けい子: Aminobenzyl penicillin (ABPC) およびAminocyclonyl penicillin (ACPC) 経口投与によるマウスの糞便菌叢の変化および盲腸重量の変化について. Chemotherapy 23: 3192-3196, 1975 8) 金井泉, 金井正光他: 尿検査法. 臨床検査法提要 (金井泉, 金井正光編), H: 32頁, 金原出版, 1975 1) MORIM0TO, S.; Y. TAKAHASHI, Y. WATANABE & S. OMURA: Chemical modification of erythromycin. I. Synthesis and antibacterial activity of 6-O-methylerythromycins A. J. Antibiot. 37 (2): 187-189, 1984 5) CHESTERMAN, H.; D. F. NEWTON, S. K. MAJEED, 樽本保男, 大島隆, 中根貞雄: TE-031の毒性研究 (第8報) サルの亜急性毒性試験. 基礎と臨床 22 (7): 1502-1532, 1988 2) 大島隆, 渡辺隆, 中村勇, 木村正明, 土田武司, 中根貞雄: TE-031の毒性研究 (第4報) ラットの亜急性毒性試験. Chemotherapy 36 (S-3) 1988 4) 樽本保男, 阪川隆司, 川西正彦, 森泉高弘, 酒井茂, 中根貞雄, 三好幸二, 須藤鎮世: TE-031の毒性研究 (第10報) イヌの慢性毒性試験. 基礎と臨床22 (7): 1533-1563, 1988 |
References_xml | |
SSID | ssib001106282 ssj0000626693 ssib031782880 ssib005879733 ssib008506721 |
Score | 1.2047548 |
Snippet | TE-031 (A-56268), a new macrolide antibiotic, was administered orally to Wistar rats at doses of 1.6, 8, 40 and 200 mg/kg/day for 6 months to determine the... |
SourceID | jstage |
SourceType | Publisher |
StartPage | 311 |
Subtitle | CHRONIC TOXICITY IN RATS |
Title | TOXICITY STUDIES ON TE-031 (A-56268) IX |
URI | https://www.jstage.jst.go.jp/article/chemotherapy1953/36/Supplement3/36_Supplement3_311/_article/-char/en |
Volume | 36 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
ispartofPNX | CHEMOTHERAPY, 1988/07/30, Vol.36(Supplement3), pp.311-333 |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV3Nj5QwFG_GNTFejEaN3-FgombtuNAW2iOZjFInO-guE9kTKbQcJnF3s5k96L_kP-krBaazeliNXgg0tKG81x-_V94HQi-BEShBdYR1rRpMG8axAizGQBVIq0MSG2MDnA-XcbaiH0tWTiY_PK-ly009bb7_Nq7kb6QKbSBXGyX7B5IdB4UGOAf5whEkDMfryTgv5UwWJwOv28-X-8UcwwqyxDHFwDpibu1-Wfok1KZByItsfpR-Golsnh1n8jB1fnyLFC5GPEg_yA4O5ks52zbDPWnXni7k0agG8guAeHG86pB9tci3mwqhcIX1HNTDJ9qWvhydRjunEPO1Dwf7toOlAhDcVXqYGgefnFPMuCtbPOCrS3DS61FXq7Tb-CQebJIecN0XmLjUGL-CO9A1EEnjPY79CTgl8dQbthoH20mj3Quputq7InG10_vKJdhH267qAtTuBroZJWBWWg-Az94vx9CGo3q5z3giEo9L29SAXi464G1g7Pbg6WgDcCUxVv6zb_YWejvM-901Zg0kag0mxeCO2DGk4i6605s2QermcQ9N1uo-ejXoaNDraJAvA6ejweteQ98EsnyAVu_nxSzDfXEOvI5CusEtDRsKtr6INSOwoFmto5ZzTeooOahJawhLas0iHQmumgMDPJopW26ZqqQV1JCHaO_07NQ8QgGJLUlOaNvWimpg0LURsb1bsRbYo3iMTty8qnOXgaX6d8J88h_Hfopu27XlNuyeob3NxaV5DhR2U7_oVOcnQvyU4g |
link.rule.ids | 315,786,790,4043,27956,27957,27958 |
linkProvider | Colorado Alliance of Research Libraries |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=TOXICITY+STUDIES+ON+TE-031+%28A-56268%29+IX&rft.jtitle=CHEMOTHERAPY&rft.au=OHSHIMA%2C+TAKASHI&rft.au=YAGI%2C+KENICHI&rft.au=KASAI%2C+AKIRA&rft.au=IWAMATSU%2C+YUKO&rft.date=1988&rft.pub=Japanese+Society+of+Chemotherapy&rft.issn=0009-3165&rft.eissn=1884-5894&rft.volume=36&rft.issue=Supplement3&rft.spage=311&rft.epage=333&rft_id=info:doi/10.11250%2Fchemotherapy1953.36.Supplement3_311&rft.externalDocID=article_chemotherapy1953_36_Supplement3_36_Supplement3_311_article_char_en |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0009-3165&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0009-3165&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0009-3165&client=summon |